Robert Pengelly

Nov 22, 2024 | nature.com | Rachel L. Paterson |Rakesh Kulkarni |Richard Suckling |Vijaykumar Karuppiah |Robert Pengelly |José Donoso | +14 more

AbstractThe non-polymorphic HLA-E molecule offers opportunities for new universal immunotherapeutic approaches to chronic infectious diseases. Chronic Hepatitis B virus (HBV) infection is driven in part by T cell dysfunction due to elevated levels of the HBV envelope (Env) protein hepatitis B surface antigen (HBsAg).